Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65
- PMID: 18223389
- DOI: 10.1097/MPG.0b013e318156e139
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65
Comment on
-
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.Gastroenterology. 2007 Jan;132(1):52-65. doi: 10.1053/j.gastro.2006.11.041. Epub 2006 Nov 29. Gastroenterology. 2007. PMID: 17241859 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
